X0306 4 2022-06-06 0 0001642545 Shockwave Medical, Inc. SWAV 0001404227 Godshall Douglas Evan C/O SHOCKWAVE MEDICAL, INC. 5403 BETSY ROSS DRIVE SANTA CLARA CA 95054 1 1 0 0 President & CEO Common Stock 2022-06-06 4 M 0 7400 3.416 A 150326 D Common Stock 2022-06-06 4 S 0 2270 176.73 D 148056 D Common Stock 2022-06-06 4 S 0 5016 177.53 D 143040 D Common Stock 2022-06-06 4 S 0 14 178.36 D 143026 D Common Stock 2022-06-06 4 S 0 66 179.58 D 142960 D Common Stock 2022-06-06 4 S 0 34 181.29 D 142926 D Stock Option 3.416 2022-06-06 4 M 0 7400 0.00 D 2027-05-09 Common Stock 7400 454799 D All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 2/27/2022. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $176.13 to $177.12. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $177.14 to $177.97. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. All reported securities were sold at a price of $178.36. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $179.50 to $180.05. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $180.91 to $181.30. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Twenty-Five percent of the shares subject to this option vested on 5/9/18 and the balance of the shares vested in equal monthly installments. /s/ Wade Estey, as attorney-in-fact for Douglas Godshall 2022-06-08